Tenaya Therapeutics
PublicLast Round
Follow-on Offering
Dec 15, 2025
Total Funding Raised
$626.7M
Company Overview
Tenaya Therapeutics (NAS: TNYA) is a biotechnology company dedicated to discovering and developing curative therapies targeting the root causes of heart disease through gene therapy, cellular regeneration, and precision medicine.
Sector
Healthcare
AI Layer
Non-AI
Keywords
cardiac gene therapyadeno-associated virus (AAV) vector-based therapytherapeutics for genetic heart diseasecellular regeneration for heart diseaseprecision medicine for cardiovascular diseaseone-time infusion therapy for heart diseaseMYBPC3 hypertrophic cardiomyopathy gene therapyPKP2 arrhythmogenic cardiomyopathy gene therapysmall molecule for heart failure with preserved ejection fraction (HFpEF)in vivo cardiac fibroblast reprogramminghiPSC-CM models for cardiac drug discoverycGMP manufacturing for AAV gene therapyclinical-stage cardiac biotechnology
Tenaya Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Tenaya Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Dec 15, 2025 | ||||
| Follow-on Offering | Mar 5, 2025 | ||||
| Grant | Feb 3, 2025 | ||||
| Follow-on Offering | Feb 8, 2024 | ||||
| Grant | Jun 24, 2022 | ||||
IPO Announced | Jul 30, 2021 |
Tenaya Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Column Group | Series C, Follow-on Offering, Series B, Series A |
| Soleus Capital | Follow-on Offering |
| RA Capital Management | Follow-on Offering, Series C |
| GV | Series C, Series B |
| Waycross Ventures | Series C |
| Integral Health Asset Management | Follow-on Offering |
| Fidelity Management & Research Company | Series C |
Tenaya Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Firmographic Details
HeadquartersSouth San Francisco, California
Employee Range96
Year Founded2016
Last FundingDec 15, 2025